U.S. markets close in 2 hours 40 minutes
  • S&P 500

    3,936.13
    -62.71 (-1.57%)
     
  • Dow 30

    33,554.21
    -392.89 (-1.16%)
     
  • Nasdaq

    11,024.66
    -215.28 (-1.92%)
     
  • Russell 2000

    1,813.32
    -26.90 (-1.46%)
     
  • Crude Oil

    73.85
    -3.08 (-4.00%)
     
  • Gold

    1,783.40
    +2.10 (+0.12%)
     
  • Silver

    22.35
    -0.06 (-0.28%)
     
  • EUR/USD

    1.0477
    -0.0021 (-0.20%)
     
  • 10-Yr Bond

    3.5660
    -0.0330 (-0.92%)
     
  • GBP/USD

    1.2167
    -0.0027 (-0.22%)
     
  • USD/JPY

    136.9170
    +0.2320 (+0.17%)
     
  • BTC-USD

    16,958.25
    -126.55 (-0.74%)
     
  • CMC Crypto 200

    399.49
    -2.31 (-0.57%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,885.87
    +65.47 (+0.24%)
     

Novavax stock up 4.4% premarket after it says 1 million COVID vaccine doses now available in the U.K.

Novavax stock up 4.4% premarket after it says 1 million COVID vaccine doses now available in the U.K.

Novavax Inc. said Tuesday that one million doses of its protein-based COVID vaccine Nuvaxovid are now available in the U.K. "With U.K. data showing that people infected with both COVID-19 and the flu are more than five times as likely to die compared to someone with no infection(1) , it is more important than ever to consider any vaccine offered to you by the National Health Service," said Stanley C. Erck, Novavax chief executive, in a statement. The Novavax vaccine uses more conventional techno